BUYER READINESS
Buyer readiness is the diagnostic framework that measures a prospect's capacity to make a purchase decision across four dimensions: Problem Conviction, Evaluation Clarity, Outcome Confidence, and Organizational Readiness. Research shows 40-60% of qualified B2B pipeline ends in "no decision," not because buyers chose a competitor, but because unresolved gaps in these four dimensions created indecision that killed the deal.
Not lost to a competitor.
Not killed by budget.
The buyer couldn't decide.
The research explains why. The diagnostic tells you which deals are at risk. The protocols tell you what to do about each one.
This is the definitive research guide to buyer decision readiness in B2B sales: what causes it, how to measure it, and how to resolve it before the deal goes silent.
You recognize this.
You have leads. You have meetings. You have a pipeline your board calls healthy. What you don't have is a clean explanation for why the deals that looked like wins in February are closed-lost by March. Not lost to a competitor. Not killed by a budget freeze. Just gone. Quiet. The kind of loss that shows up in your CRM as "no decision" and in your forecast as a number nobody can account for.
You know the deal. The champion was engaged. They asked sharp questions, introduced their VP, followed up the same day. Your rep walked out of that meeting thinking it was closed. Then two weeks of silence. Then a one-line email: "We've decided to hold off for now." Your team runs the retrospective. No one knows. Everyone has a theory. And every theory leads to the same response: try harder next time. Send more content. Add another touchpoint. Refine the pitch. None of it addresses what actually broke because nobody diagnosed what actually broke.
Here is what that pattern is actually costing you. Not just the deal. The deal is already gone. It's costing you every deal that will follow the same trajectory this quarter because you don't know which part failed. Your team is optimizing sales execution when the breakdown happened before the first real conversation started. They're refining pricing when the buyer never got far enough to care about price. Every quarter, you run the same play against the same invisible wall and call the result "a long sales cycle." It is not a long sales cycle. It is an undiagnosed failure that repeats.
What the data actually says
Most B2B sales teams believe their biggest threat is the competitor with a better feature set or a lower price point. The data says otherwise.
The most common way to lose a B2B deal is for the buyer to do nothing at all.
Indecision is not the status quo
Sales teams tend to lump all inaction together. A buyer who chose to stay with their current solution and a buyer who could not bring themselves to make any decision at all get the same label: closed-lost. This is a diagnostic mistake with expensive consequences.
Why this distinction matters
Status quo preference means the buyer evaluated your offer and decided the pain of switching outweighed the pain of staying. That is a competitive loss. The right response is a stronger value case.
Buyer indecision means the buyer wanted to move forward but could not complete the internal process required to say yes. That is a readiness failure. The right response is reducing the fear of making the wrong choice.
Applying traditional sales pressure to an indecisive buyer, the move 73 percent of sellers default to, degrades win rates by 84 percent (Dixon & McKenna, 2022).
Pushing harder is the most destructive move in the research. Applying traditional sales pressure to an indecisive buyer degrades win rates by 84 percent.
The behavioral science of getting stuck
Three decades of decision science explain why buyers freeze. This is not weakness or disinterest. It is predictable psychology operating at the organizational level.
Loss aversion
Buyers feel losses approximately 2.25 times more intensely than equivalent gains (Kahneman & Tversky, 1979). A buyer evaluating your product is not weighing the upside of switching against the downside. They are weighing the upside of switching against 2.25 times the perceived risk of making a mistake.
In B2B, this effect compounds because the decision-maker spends company money but risks personal reputation. Global replication has confirmed the loss aversion coefficient across cultures (Columbia University, 2022).
Omission bias (FOMU > FOMO)
People experience stronger regret from actions that cause harm than from inactions that allow harm, even when outcomes are identical (Ritov & Baron, 1992). The pattern shows up in every B2B evaluation where the perceived risk of switching outweighs the known cost of staying.
In practice: your buyer knows their current solution is inadequate. They also know that choosing your product and having it fail will feel worse than doing nothing and living with the inadequacy. The math is irrational. The behavior is universal.
Three drivers of indecision
Buyer indecision decomposes into three distinct factors (Germeijs & De Boeck, 2003):
Valuation problems: the buyer cannot assess relative worth.
Information gaps: the buyer feels under-researched.
Outcome uncertainty: the buyer fears the result will not materialize.
Originally identified in decision-theory research on career choice, this three-factor model was subsequently confirmed in B2B sales data across 2.5 million recorded conversations. Each factor requires a different intervention. Applying the wrong one wastes the interaction and deepens the buyer's uncertainty.
The 87% reality
Your pipeline is not full of people who are ready to decide. It is full of people who want to decide but cannot.
What most sellers do (and why it backfires)
Seventy-three percent of sellers respond to this indecision by relitigating the status quo: re-presenting the case for change, adding more proof points, intensifying urgency (Dixon & McKenna, 2022).
This is the exact behavior that degrades win rates by 84 percent. The math is brutal: the default move for most sales teams is the move most likely to lose the deal.
The buyer's timeline
By the time your rep gets the meeting, most of the decision has already happened without you.
How little time you actually get
Eighty percent of the journey is self-directed research, peer consultation, and internal discussion (Gartner, 2023). Only 25 percent of buyers who rate supplier information as highly consistent report a high-quality, low-regret purchase (Gartner, 2019).
That last finding reframes the entire problem. Information consistency now matters more than information volume. The problem is not that buyers cannot decide. The problem is that buyers cannot trust the information they receive during the sales process.
Your sales process is not where decisions get made. It is where incomplete decisions get exposed.
The four dimensions of buyer readiness
Every deal in your pipeline rests on four buyer readiness states. When a deal stalls, one or more of these states is incomplete. Not postponed. Not deprioritized. Incomplete.
The research above comes from Dixon, Kahneman, Tversky, Forrester, Gartner, and dozens of independent studies spanning decades and millions of conversations. What none of that research provides is an operational framework that translates the findings into something a sales team can measure and act on before a deal goes dark.
That is what the four-dimension model does. I built this framework by synthesizing the behavioral science (loss aversion, omission bias, choice overload), the sales data (56% indecision, 87% moderate-to-high uncertainty, 84% win-rate degradation from pressure), and seventeen years of watching B2B deals die from the content strategy side of the room. The four dimensions below are not Dixon's taxonomy or Kahneman's theory applied directly. They are a diagnostic layer that sits on top of the research, translates it into four measurable buyer states, and maps each state to a specific intervention protocol.
Each dimension is a readiness state the buyer either has or doesn't. Each protocol is the intervention that moves the buyer from incomplete to ready.
Problem Conviction
The pattern
You recognize this when a prospect says "this is really cool" but cannot describe what staying the same is costing them. They like your product. They cannot justify buying it. The language is a tell: "interesting," "impressive," "we should definitely explore this." All energy, no urgency.
The research
This is the loss aversion gap in action. Buyers feel losses approximately 2.25 times more intensely than equivalent gains (Kahneman & Tversky, 1979). To justify the perceived risk of changing, the buyer needs to feel the cost of not changing at more than double the intensity. Forty-four percent of inaction losses are pure status quo preference (Dixon & McKenna, 2022). Without conviction that the problem is real, urgent, and personally theirs to solve, every conversation your rep has lands as interesting content. Not a buying trigger.
The fix: Urgency Protocol
The Urgency Protocol builds the case for change before the first real sales conversation. The buyer arrives already knowing what the status quo is costing. Not because your rep told them. Because the diagnostic made it visible.
What changes: The conversation shifts from "let me show you what we do" to "here's how we fix the problem you already know you have." The buyer has already seen the cost of inaction quantified in their own terms, using their own metrics. They are not waiting for your rep to build urgency because urgency arrived before the meeting did. The 2.25x loss aversion gap that blocked the decision is now working in your favor, because the buyer quantified the cost themselves. The deal advances because the buyer has their own reason to move it, not because your rep applied enough pressure to manufacture one.
Evaluation Clarity
The pattern
You recognize this when a buyer says the demo was "really helpful" but cannot tell you what they are comparing you against or what criteria would make them say yes. They are stuck in research mode. More vendors, more features, more internal conversations that generate information without generating a decision.
The research
Buyers experiencing contradictory or overwhelming information are 153 percent more likely to settle for a smaller, less disruptive solution than originally planned (Gartner, 2019). The more they research, the less confident they become.
In the Vanguard 401(k) study, every ten additional fund options reduced enrollment by approximately two percent (Iyengar et al.; as cited in Schwartz, 2004). Choice does not enable decisions. Past a threshold, choice prevents them.
Sellers who offer proactive guidance, a recommended path instead of more options, improve win rates by 144 percent (Dixon & McKenna, 2022).
The fix: Framework Protocol
The Framework Protocol gives buyers a decision framework they trust before the sales process begins. Not your framework. A framework that accounts for their specific evaluation criteria, competitive alternatives, and internal priorities. The buyer arrives knowing what they are deciding between and what "good enough" looks like.
What changes: The buyer stops collecting vendors and starts comparing against criteria they already own. The evaluation shifts from open-ended ("tell me about your product") to structured ("here's what matters to us, show me how you perform against it"). Your rep is no longer one of six undifferentiated options in a spreadsheet. They are being measured against a framework the buyer trusts, which means the conversation produces a decision instead of another round of research.
Outcome Confidence
The pattern
You recognize this when a prospect spends every conversation asking about integrations, onboarding timelines, or edge cases specific to their setup. They are not evaluating business impact. They are stress-testing whether this will actually work in their environment. Every question is a risk calculation, not a buying signal.
The research
Forty-three percent of B2B buyers make defensive purchase decisions more than 70 percent of the time (Forrester, 2026). The default mode is self-protection, not opportunity capture.
Setting clear outcome expectations improves win rates by 155 percent, yet this behavior appears on only 19 percent of sales calls (Dixon & McKenna, 2022).
This is the most underused, highest-impact seller behavior in the entire body of research.
The fix: Proof Protocol
The Proof Protocol bridges the gap with implementation evidence, reference architecture, and integration clarity before the deal reaches evaluation. The buyer arrives knowing what success looks like in their specific context, with proof that it has worked in comparable environments. The conversation becomes confirmation, not interrogation.
What changes: The questions shift from defensive ("will this work with our stack?") to forward-looking ("when can we start?"). The mechanism is specific: the buyer has already seen implementation evidence from a comparable environment, so the risk calculation that was blocking the decision has been resolved before the conversation reaches negotiation. The champion goes to their CFO with a business case that includes risk mitigation, not just ROI projections. The protocol turns the most underused, highest-impact seller behavior in the research into a systematic step instead of an accident.
Organizational Readiness
The pattern
You recognize this when a champion says "I need to run this by my team" and then goes silent for two weeks. They did not lose interest. They did not find a competitor. They lost momentum inside their own organization. The internal politics, the budget approval process, the stakeholder who was never in the room but has veto power: these are the forces that killed the deal, and your CRM will never surface them.
The research
86 percent of B2B purchases stall during the buying process (Forrester, 2024). 74 percent of B2B buyer teams demonstrate unhealthy conflict during the decision process (Gartner, 2025). The average buying group now involves 13 stakeholders across multiple departments (Forrester, 2024).
Buying groups that achieve consensus are 2.5 times more likely to report high-quality deals (Gartner, 2024). Your champion is not your closer. Your champion is one voice in a room of thirteen, and most of those rooms are fighting.
The fix: Alignment Protocol
The Alignment Protocol navigates the committee before the deal reaches a decision point, not after it stalls. It maps the buying group, identifies where conflict is likely, and equips your champion with the internal materials and arguments they need to build agreement. The deal does not depend on your champion selling alone inside their company with none of your context and all of the internal politics.
What changes: Your champion has a playbook for internal selling: who to talk to, in what order, with what materials. The mechanism is organizational mapping. The stakeholder in finance who would have killed the deal with a question nobody anticipated has been identified and their objection pre-addressed. The timeline that would have slipped because legal needed three weeks nobody planned for is built into the schedule. Buying groups that achieve this kind of consensus are 2.5 times more likely to report high-quality deals. The protocol doesn't change the politics. It maps them before the deal stalls instead of discovering them after the silence.
The weakest link principle
These four dimensions are not independent checkboxes. They form a chain. Your deal moves at the speed of the weakest link. You can max out three dimensions and still lose the deal because the fourth was never addressed.
This is why pipeline reviews miss what is actually happening. Stage progression, email opens, meeting attendance: these measure activity, not decision completeness. A deal can advance through every stage in your CRM and die because one dimension was never resolved.
How cascade failures work
Conviction without Clarity. The sales leader who creates genuine urgency but gives the buyer no direction to move in. The buyer feels the problem acutely. They understand what the status quo is costing them. But they have no framework for evaluating solutions, no criteria for deciding between options. The result: frantic vendor research, ten browser tabs open, three demos scheduled in the same week, and decision fatigue that builds with every conversation. Eventually, they retreat to the status quo they just admitted was broken. Not because they stopped believing the problem was real. Because they could not see a clear path through the options to a decision.
Clarity without Confidence. The buyer who has a clean decision framework and no reason to trust that your specific solution will work inside it. They compare vendors clearly. They score products on their criteria. And they choose someone else, or worse, they choose nothing because no option clears their confidence threshold. Your product scored well on paper. The buyer still could not picture it working in their environment, with their team, on their timeline. The spreadsheet said yes. Their gut said "what if it doesn't work?" The gut won.
Confidence without Readiness. The champion who believes in the product, has done the research, and is ready to sign. And cannot get internal approval. They go silent, not because they changed their mind, but because their organization cannot close. Budget is unallocated. The timeline conflicts with another initiative nobody mentioned during discovery. A stakeholder in legal or IT or finance who was never in the room has questions that nobody anticipated. Your champion is now selling alone inside their company with none of your context, none of your materials, and all of the internal politics you never mapped. This is the deal that "almost closed" every quarter for six months.
Why your CRM can't see this
Every one of these cascade failures looks identical in your CRM: a deal that moved through stages and then went quiet. The activity log looks healthy. The emails were opened. The meetings were attended. But activity is not the same as decision completeness, and no pipeline metric measures whether all four readiness states were actually complete. That is the gap.
One incomplete decision is enough to kill a deal. The failure mode is always the same: silence.
The only way to catch a cascade before it kills the deal is to measure all four dimensions simultaneously. That is what the diagnostic does.
What traditional methodologies miss
The methodologies your team uses are good at what they were designed to do. The problem is what they were never designed to measure.
MEDDIC is excellent at qualifying whether a deal has the right economic conditions: the budget, the decision process, the metrics that justify the spend. It was never designed to measure whether the buyer has completed the internal decisions that make those conditions actionable.
BANT identifies budget, authority, need, and timeline. It does not check whether the buyer has conviction that the problem justifies the budget, or confidence that this specific solution will deliver the outcome. A deal can pass every BANT criteria and still die because the buyer could not resolve their internal uncertainty.
Challenger teaches sellers how to reframe the buying conversation with commercial insight. It is one of the most influential sales methodologies of the last seventeen years, and it has earned that position. It does not diagnose whether the buyer arrived ready to have that conversation in the first place. A brilliantly reframed conversation with an unready buyer is still a conversation that does not close.
SPIN Selling uncovers needs through structured questioning. It is rigorous, well-researched, and effective at surfacing problems the buyer had not articulated. It does not score whether those uncovered needs have translated into decision readiness or remain as acknowledged but unresolved problems sitting in the buyer's mind.
The gap these methodologies share
Each methodology above answers an important question: MEDDIC: Does this deal have the right conditions? BANT: Is this opportunity qualified? Challenger: How should the seller engage? SPIN: What needs has the buyer articulated?
None of them answer: Is the buyer actually ready to make this decision?
For a detailed analysis of each category: What MEDDIC Cannot See · Why Sales Training Doesn’t Fix Buyer Indecision · What Revenue Intelligence Cannot Predict · The Complete Solution Landscape
Every one of these methodologies assumes the buyer is ready to evaluate. None of them measure whether that assumption is true.
That gap is not a minor oversight. It is a missing layer in how B2B sales has been practiced for decades. Qualification frameworks measure deal conditions. Engagement methodologies shape seller behavior. Neither one diagnoses the buyer's actual decision state. Buyer readiness is the layer that sits between qualification and closed revenue, and until now, no framework has existed to measure it.
I built the four-dimension model to fill that gap. Not as a replacement for MEDDIC or Challenger, but as the diagnostic layer that makes them work. See how every tool in the revenue stack fits together →
What changes when you diagnose before the deal goes dark
If these four dimensions are measurable, the next question is what measuring them actually looks like, and what changes in your pipeline when you do.
What DecisionScope™ does
DecisionScope is the diagnostic I built to operationalize the four-dimension framework. It scores your pipeline against Problem Conviction, Evaluation Clarity, Outcome Confidence, and Organizational Readiness using a structured assessment that replaces guesswork with evidence. Instead of asking "where is this deal stuck?" and getting theories, you get a readiness score across all four dimensions with specific evidence for each rating.
Each gap maps to a specific protocol: Low Problem Conviction? The Urgency Protocol builds the case for change before the deal advances. Weak Evaluation Clarity? The Framework Protocol gives the buyer a decision framework they trust. Missing Outcome Confidence? The Proof Protocol provides implementation evidence tailored to their context. Incomplete Organizational Readiness? The Alignment Protocol maps the buying group and equips your champion.
Before and after
Without the diagnostic, your team spends pipeline reviews debating why deals stalled. The conversation is theory-driven: "I think they're comparing us to a competitor." "I think the champion lost interest." "I think we need a better pitch." Every deal gets the same response: more follow-up, more content, more pressure. Some close anyway. Most don't. You never know why the ones that closed were different from the ones that didn't.
With the diagnostic, your team knows which dimension is incomplete before the deal goes silent. The response is specific: this deal scores low on Problem Conviction and needs the Urgency Protocol, this one has incomplete Organizational Readiness and needs the Alignment Protocol, this one is ready and just needs a Proof bridge on Outcome Confidence. Your reps stop guessing and start prescribing. Pipeline reviews take half the time because the data replaces the debate.
What your Monday morning looks like
Picture the pipeline review. Your VP pulls up the dashboard. Instead of fifty deals in "Stage 3" with no context, they see: twelve deals with incomplete Problem Conviction, eight with incomplete Organizational Readiness, three ready to close. The conversation changes. Instead of "what's the update on Acme?" it's "Acme scored low on Outcome Confidence. What evidence package did we send?"
Reps stop spending Thursday afternoons writing "just checking in" emails to buyers who went silent. They spend that time running protocols on deals where the diagnosis tells them exactly what's missing. The activity doesn't increase. The relevance of the activity does. And the buyers notice, because they're getting preparation instead of pressure.
What this means for your numbers
The difference between diagnosis-only and diagnosis plus recommendation is the difference between a 14 percent close rate and a 36 percent close rate (Dixon & McKenna, 2022). The protocols are the recommendation layer. They turn the diagnostic from a report into an intervention.
Your pipeline doesn't need more leads. It needs more completed buyer decisions. That is what DecisionScope measures and what the four protocols resolve.
What this means for your pipeline right now
Pull up your last ten closed-lost deals. For each one, ask: which of the four dimensions was incomplete?
Did the buyer have conviction that the problem was worth solving? Did they have clarity on how to evaluate solutions? Did they have confidence that your product would work in their environment? Did their organization have the internal readiness to make the purchase?
You will find that most of your losses cluster around one or two dimensions. That is not a coincidence. It is a structural gap in how your buyers get prepared before they see your product.
If you are doing this exercise and want a structured read rather than more theories, the free assessment takes four minutes.
The free assessment shows you which dimensions are weak across your pipeline. It takes four minutes and gives you a readiness score for each dimension. The full DecisionScope diagnostic goes deeper: it scores individual deals with specific evidence, identifies the exact gaps blocking each one, and maps each gap to the protocol that resolves it. The free version tells you where to look. The full version tells you what to do.
The fix is not better presentations. Your pitch is probably fine. The fix is not more pipeline. You already have pipeline. The fix is diagnosing which dimensions break down most often in your deals and building the preparation that ensures those readiness states are complete before the deal reaches a decision point.
This is the shift from optimizing sales execution to diagnosing buyer readiness. From asking "how do we sell better?" to asking "what does the buyer need to resolve before anything we say matters?"
Every deal you close this quarter will close because the buyer was ready across all four dimensions. Every deal you lose will lose because at least one dimension was incomplete. The only variable is whether you knew which one it was in time to do something about it.
Frequently asked questions about buyer readiness
What is buyer readiness in B2B sales?
Buyer readiness is the state in which a B2B buyer has reached completeness across four dimensions required for a purchase: Problem Conviction (belief that the problem justifies action), Evaluation Clarity (a framework for comparing options), Outcome Confidence (trust that the chosen solution will work in their environment), and Organizational Readiness (internal alignment across all stakeholders). A buyer who is incomplete on any dimension will stall regardless of how strong the product, pitch, or sales process is. Most B2B deals that end in "no decision" fail because one or more of these dimensions was never resolved.
Why do so many B2B deals end in no decision?
Between 40 and 60 percent of qualified B2B deals end in no decision (Dixon & McKenna, 2022), confirmed by independent studies showing 61 percent indecision-driven losses (Ebsta & Pavilion, 2024) and 53 percent no-decision outcomes (Challenger Inc., 2024). The primary cause is buyer indecision, not competition or status quo preference. Indecision accounts for 56 percent of all inaction losses. Buyers want to move forward but cannot complete the internal decision process due to loss aversion, information overload, outcome uncertainty, or organizational misalignment. Traditional sales tactics that increase pressure on indecisive buyers degrade win rates by 84 percent.
What is the difference between buyer indecision and status quo preference?
Status quo preference means the buyer evaluated the offer and consciously chose to stay with their current solution. The pain of switching outweighed the pain of staying. This is a competitive loss. Buyer indecision means the buyer wanted to move forward but could not resolve the internal barriers to making a decision: fear of making the wrong choice, inability to build organizational consensus, or lack of confidence in the outcome. These two causes account for 56 percent (indecision) and 44 percent (status quo) of inaction losses respectively (Dixon & McKenna, 2022). They require fundamentally different interventions. Treating indecision like status quo preference, which 73 percent of sellers do, makes the problem worse.
How do I know which dimension is stalling my deals?
Review your last ten closed-lost deals and ask four questions for each: Did the buyer articulate a clear cost of inaction? (Conviction.) Did the buyer have a structured framework for evaluating options? (Clarity.) Did the buyer express confidence that the solution would work in their specific environment? (Confidence.) Did all required stakeholders align before the decision deadline? (Readiness.) Most sales organizations find that their losses cluster around one or two dimensions, not all four. The DecisionScope free assessment provides a structured four-minute version of this diagnostic for your current pipeline.
How does buyer readiness relate to MEDDIC and other sales methodologies?
Buyer readiness is not a replacement for MEDDIC, BANT, Challenger, or SPIN. It measures a different thing. Those methodologies qualify deals (does this opportunity have the right conditions?) and guide seller behavior (how should the rep engage?). Buyer readiness measures whether the buyer has reached completeness across the four dimensions required to act on those conditions. A deal can pass every MEDDIC criterion, every BANT qualification, and still die because the buyer never resolved their outcome uncertainty or their internal team never reached consensus. Buyer readiness is the diagnostic layer beneath qualification: it determines whether a qualified deal can actually close.
What is the difference between buyer readiness and sales qualification?
Sales qualification asks: "Should we invest time in this deal?" It filters opportunities based on budget, authority, need, timeline, and economic conditions. Buyer readiness asks: "Can this buyer actually complete a purchase?" It measures the buyer's internal state across four dimensions. A deal can be fully qualified and completely unready. The buyer has budget, authority, and need, but cannot build internal consensus or lacks confidence that the solution will deliver. Qualification tells you which deals to pursue. Readiness tells you which deals can close, and what needs to happen before they can.
How long does it take to diagnose buyer readiness?
The free self-assessment takes four minutes and provides a preliminary readiness score across all four dimensions. The full DecisionScope diagnostic, which includes pipeline analysis, dimension scoring with evidence, and protocol recommendations, is completed within five business days. Most sales leaders report that the four-minute assessment alone changes how they think about their current pipeline, because it reframes "stuck deals" as specific, diagnosable dimension gaps rather than mysteries.
References
Adamson, B., Dixon, M., Spenner, P., & Toman, N. (2015). The Challenger customer. Portfolio/Penguin.
Challenger Inc. (2024). Sales research data.
Columbia University Mailman School of Public Health. (2022). Global study confirms influential theory behind loss aversion.
Dixon, M., & McKenna, T. (2022). Stop losing sales to customer indecision. Harvard Business Review.
Ebsta & Pavilion. (2024). B2B sales benchmark report.
Forrester. (2024). The state of business buying, 2024.
Forrester. (2026). B2B buying psychology research (as cited in Corporate Visions).
Gartner. (2019, July 29). New B2B sales approach to win in today's information age [Press release].
Gartner. (2025, May 7). 74% of B2B buyer teams demonstrate unhealthy conflict during the decision process [Press release].
Germeijs, V., & De Boeck, P. (2003). Career indecision: Three factors from decision theory. Journal of Vocational Behavior, 62(1), 11–25.
Kahneman, D., & Tversky, A. (1979). Prospect theory: An analysis of decision under risk. Econometrica, 47(2), 263–292.
Ritov, I., & Baron, J. (1992). Status quo and omission biases. Journal of Risk and Uncertainty, 5(1), 49–61.
Schwartz, B. (2004). The paradox of choice: Why more is less. HarperCollins. (Citing Iyengar, S. S., Jiang, W., & Huberman, G., Vanguard 401(k) study).
6sense. (2025). Buyer experience report.
The next deal that goes quiet in your pipeline will go quiet for a reason
The question is whether you'll know the reason before the silence starts. The free buyer readiness assessment takes four minutes. It scores your current pipeline against all four dimensions and shows you where the gaps are. No pitch. No commitment. Just a diagnostic read on the deals you can still save this quarter.